home / stock / livn / livn quote
Last: | $55.94 |
---|---|
Change Percent: | 0.02% |
Open: | $55.86 |
Close: | $55.94 |
High: | $56.715 |
Low: | $55.86 |
Volume: | 380,769 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$55.94 | $55.86 | $55.94 | $56.715 | $55.86 | 380,769 | 03-28-2024 |
$55.87 | $54.69 | $55.87 | $56.32 | $54.63 | 416,464 | 03-27-2024 |
$54.39 | $54.83 | $54.39 | $55.36 | $54.28 | 811,121 | 03-26-2024 |
$54.42 | $56.17 | $54.42 | $56.44 | $54.35 | 394,030 | 03-25-2024 |
$55.98 | $56.37 | $55.98 | $56.56 | $55.52 | 519,752 | 03-22-2024 |
$56.28 | $56.8 | $56.28 | $57.08 | $55.965 | 1,435,391 | 03-21-2024 |
$56.63 | $51.25 | $56.63 | $57.18 | $51.22 | 2,142,214 | 03-20-2024 |
$50.34 | $50.63 | $50.34 | $50.95 | $50.04 | 479,979 | 03-19-2024 |
$50.76 | $50.54 | $50.76 | $50.84 | $49.695 | 576,728 | 03-18-2024 |
$50.6 | $50.68 | $50.6 | $51.2 | $50.04 | 780,835 | 03-15-2024 |
$51.12 | $52.41 | $51.12 | $52.41 | $50.69 | 630,896 | 03-14-2024 |
$52.28 | $51.67 | $52.28 | $52.89 | $51.61 | 481,652 | 03-13-2024 |
$51.98 | $52.12 | $51.98 | $52.21 | $51.14 | 766,852 | 03-12-2024 |
$52.6 | $53.75 | $52.6 | $54.21 | $52.5 | 566,958 | 03-11-2024 |
$53.73 | $54.52 | $53.73 | $54.825 | $53.2 | 579,029 | 03-08-2024 |
$53.94 | $53.88 | $53.94 | $54.565 | $53.32 | 889,499 | 03-07-2024 |
$53.26 | $52.38 | $53.26 | $54.14 | $50.97 | 3,381,318 | 03-06-2024 |
$52.38 | $52.81 | $52.38 | $55.12 | $52.3 | 2,271,788 | 03-05-2024 |
$55.85 | $55.2 | $55.85 | $55.99 | $54 | 329,731 | 03-04-2024 |
$55.24 | $54.69 | $55.24 | $55.97 | $54.24 | 531,793 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
LivaNova PLC Company Name:
LIVN Stock Symbol:
NASDAQ Market:
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its first-quarter 2024 results prior to the call. A l...
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday. Shares of Sportradar Group AG (NASDAQ: SRAD) rose sharply durin...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation , has achieved a positive predictive outcome and will conclude enrollment earlier than anticipated...